Posted in Regulatory Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters April 23, 2026 BioSpace The FDA in July 2025 made publicly available over 200 complete response letters–an initiative that the investment community sees as “unanimously positive,” analysts told BioSpace. RegulatoryRead full story